Tag: Kalbe Farma
Indonesia’s Kalbe Signs License Agreement with Genexine for US$1.1B
JAKARTA (TheInsiderStories) - PT Kalbe Genexine Biologics (KGBio), unit of private pharmaceutical company, PT Kalbe Farma Tbk (IDX: KLBF), signed a license agreement with South...
US’s General Atlantic Invests US$55M in Kalbe Genexine Biologics
JAKARTA (TheInsiderStories) - A global equity firm, General Atlantic, invested US$55 million in Kalbe Genexine Biologics (KGBio), the unit of drug-maker, PT Kalbe Farma Tbk (IDX:...
Indonesia’s Kalbe to Spend US$71M in 2021
JAKARTA (TheInsiderStories) - The pharmaceutical company, PT Kalbe Farma Tbk (IDX: KLBF) prepared capital expenditures around Rp1.1 trillion (US$78.01 million) in 2021, said the finance...
Kalbe Farma Divests Philippines’s Asset to ARC Holding
JAKARTA (TheInsiderStories) - Pharmaceutical company, PT Kalbe Farma Tbk (IDX: KLBF) divested Asiawide Kalbe Philippines Inc., stakes to ARC Holdings Inc., an American-based company....
Indonesia’s Kalbe Farma Takes Over Innolab for US$1.3M
JAKARTA (TheInsiderStories) - Drug-maker, PT Kalbe Farma Tbk (IDX: KLBF) spent Rp19 billion (US$1.29 million) to take over 60 percent the laboratory clinic firm, PT Innolab...
Indofarma to Distribute Mylan’s COVID-19 Drugs in Indonesia
JAKARTA (TheInsiderStories) - Pharmaceutical firm, PT Indofarma Tbk (IDX: INAF) ready to distribute the anti-coronavirus drug under the brand Desrem Remdesivir, the company announced today. The...
India’s Hetero, Kalbe Farma Markets COVID-19 Drugs in Indonesia
JAKARTA (TheInsiderStories) - Pharmaceutical company, PT Kalbe Farma Tbk (IDX: KLBF) officially starts the marketing of Remdesivir and Covifor, a drug for patient infected by...
Indonesia’s Kalbe Farma Prepares US$68M to Produces COVID-19 Vaccine
JAKARTA (TheInsiderStories) - A private pharmaceutical company, PT Kalbe Farma Tbk (IDX: KLBF) needs an investment up to Rp1 trillion (US$68.02 million) to produces COVID-19...
